In spite of COVID-19 the life science industry in China is still undergoing exponential growth. China has set new records in the new funds raised, VC investments, IPOs and partnering. This report, from the ChinaBio group provides an overview of 2020 and covers the opportunities available for your biotechnology start-up.
